Evidence map›Paper›PMID 32788647›Full record

ArticleLeukemia2021

Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma.

Kui Nie, David Redmond, Kenneth W Eng, Taotao Zhang, Shuhua Cheng, Susan Mathew, Olivier Elemento, Wayne Tam

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. International Consensus Classification of acute lymphoblastic leukemia/lymphoma.Virchows Archiv : an international journal of pathology · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kui NieDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
David RedmondDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
Kenneth W EngInstitute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Taotao ZhangDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
Shuhua ChengDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Susan MathewDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Olivier ElementoInstitute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Wayne TamDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. wtam@med.cornell.edu.ORCID http://orcid.org/0000-0003-4283-0005

Funding

The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma (Administrative Supplement)R01CA194547 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELEMENTO, OLIVIER, TAM, WAYNE · 2015 to 2019
$2.6M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorMutationCell Transformation, NeoplasticClonal EvolutionDisease SusceptibilityGenetic Predisposition to DiseaseHumansLymphoma, FollicularSignal TransductionBiomarkers, Tumor

Identifiers

PMID32788647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.